Stoke Therapeutics (STOK) Receivables - Other (2018 - 2026)

Stoke Therapeutics' Receivables - Other history runs 9 years deep, the most recent figure standing at $1.7 million for Q1 2026.

• In Q1 2026, Receivables - Other rose 178.88% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (up 178.88% YoY), while the FY2025 annual figure was $2.0 million, up 181.29% from the prior year.
• Receivables - Other was $1.7 million for Q1 2026 at Stoke Therapeutics, down from $2.0 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $2.0 million in Q4 2025 to a low of $11000.0 in Q1 2024.
• Historically, Receivables - Other has averaged $680529.4 across 5 years, with a median of $492000.0 in 2023.
• The sharpest annual moves came in 2024 and 2025: Receivables - Other plunged 97.76% in 2024, then surged 5409.09% in 2025.
• A 5-year view of Receivables - Other shows it stood at $588000.0 in 2022, then plunged by 89.12% to $64000.0 in 2023, then surged by 993.75% to $700000.0 in 2024, then soared by 181.29% to $2.0 million in 2025, then slipped by 14.17% to $1.7 million in 2026.
• The last three Receivables - Other figures came in at $1.7 million (Q1 2026), $2.0 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.